Ferrusi, Ilia, Jun Zhao, Dirk van Helden, and Pierre-Yves von der Weid. Cyclopiazonic acid decreases spontaneous transient depolarizations in guinea pig mesenteric lymphatic vessels in endotheliumdependent and -independent manners. Am J Physiol Heart Circ Physiol 286: H2287-H2295, 2004. First published February 19, 2004 10.1152/ajpheart.00739.2003.-Guinea pig mesenteric lymphatic vessels exhibit vasomotion through a pacemaker mechanism that involves intracellular Ca 2ϩ release and resultant spontaneous transient depolarizations (STDs) of the smooth muscle membrane potential. This study presents a detailed characterization of the effects of cyclopiazonic acid (CPA) on this pacemaker activity. Microelectrode recordings from smooth muscle in vessel segments revealed that application of CPA (1-10 M) caused a hyperpolarization accompanied by a decrease in the frequency and amplitude of STDs. The CPA-induced hyperpolarization was abolished after destruction of the endothelium and in the presence of
allows fluids to be removed from tissues, propelled along the lymphatic tree, and returned to the bloodstream; impairment leads to profound swelling and edema. Studies of lymphatic vessels from guinea pig mesentery indicate that the smooth muscle pacemaker mechanism occurs through excitatory electrical events termed spontaneous transient depolarizations (STDs). Large-amplitude STDs or summation of these events trigger action potentials and resultant constriction (48) . STDs have been suggested to be generated by the synchronized release of Ca 2ϩ from intracellular Ca 2ϩ stores in the sarcoplasmic reticulum (SR), which causes the opening of Ca 2ϩ -activated Cl Ϫ channels (44, 51, 52) . Evidence for a role of Ca 2ϩ stores has arisen from findings that increasing the intracellular concentration of Ca 2ϩ ([Ca 2ϩ ] i ; e.g., via norepinephrine administration or stretch) increases both the lymphatic pumping rate and STD activity, and that agents known to decrease [Ca 2ϩ ] i [e.g., BAPTA-acetoxymethyl ester (AM), isoproterenol, forskolin, or nitric oxide (NO)] reduce pumping rate and STD activity (2, 48, 54, 55) . The present study investigates the role of Ca 2ϩ stores in pacemaking using cyclopiazonic acid (CPA), which is an inhibitor of the store Ca 2ϩ pump. CPA, a mycotoxin from Aspergillus and Penicillium, has been described as a highly selective inhibitor of Ca 2ϩ -ATPase in skeletal, cardiac, and smooth muscle SR (13, 52) . In the latter tissue, CPA has been shown to reversibly inhibit ATPdependent Ca 2ϩ uptake of the SR in skinned ileal smooth muscle cells (45) and is proposed to do so in intact smooth muscle preparations of the aorta (8) , trachea (6) , and mesenteric artery (26) . In addition, CPA has been reported to decrease lymphatic pumping in isolated bovine mesenteric lymphatic vessels (3) . The present study presents a detailed characterization of the actions of CPA. It is found that CPA acts by two primary pathways to decrease lymphatic pacemaking and underlying STD activity.
METHODS
Tissue preparation. Guinea pigs (7-15 days of age) of either sex were killed by decapitation during deep anesthesia consequent to inhalation of halothane (5-10% in air). This procedure has been approved by the University of Calgary Animal Care and Ethics Committee and conforms to the guidelines established by the Canadian Council on Animal Care. The small intestine with attached mesentery was rapidly dissected out and placed in a physiological saline solution (PSS) of the following composition (mM): 2.5 CaCl 2; 5 KCl, 2 MgCl2, 120 NaCl, 25 NaHCO3, 1 NaH2PO4, and 11 glucose. The pH was maintained at 7.4 by constant bubbling with 95% O 2-5% CO2.
Small collecting lymphatic vessels (diameter, 80 -230 m) that supply the jejunum and ileum were dissected together with their associated artery and vein and were left intact within the surrounding mesentery. The mesentery was used to pin out the tissue onto the Sylgard-coated bottom of a small organ bath (volume, 100 l), and the preparation was mounted on the stage of an inverted microscope (TMS; Nikon). The pinning procedure appeared to exert only mild physical forces on the lymphatics; it tended to flatten the vessels but caused little if any stretch due to the vessels running inside pocketlike regions of the mesentery such that the mesentery absorbed the stretch. Such unperfused vessels showed relatively little spontaneous activity under resting conditions but could readily be stimulated by vessel perfusion or application of excitatory agonists. Experiments were performed with tissues continuously superfused with PSS heated to 36°C at a flow rate of 3 ml/min, which caused 90% changeover in Ͻ7 s.
Electrophysiology. Resting membrane potential was measured using conventional glass intracellular microelectrodes with resistances of 150 -250 M⍀ when filled with 0.5 M KCl. Electrodes were connected to an amplifier (Intra 767; World Precision Instruments; Sarasota, FL) through an Ag-AgCl half cell. Resting membrane potential was monitored on a digital oscilloscope (VC6525; Hitachi) and simultaneously recorded on a computer via an analog-to-digital converter (PowerLab/4SP, AD Instrument; Mountain View, CA). Intracellular recordings were obtained by impaling smooth muscle cells from the adventitial side of the vessels. Vessels were cut into short segments (125-350 m) with fine dissecting scissors to ensure simplified electrical properties of the smooth muscle. In this situation, electrical activity, although generated at localized foci within the smooth muscle, produces a similar potential change in all the smooth muscle cells of the segment (48) . Endothelial membrane potential recordings were obtained either by deeper penetration of the microelectrode into the vessel or by impaling the first layer of cells in a vessel that has been carefully cut open with the intima then facing up. As described in a previous study (56) , endothelial cells are more polarized than smooth muscle cells (resting membrane potential, ϳ72 vs. ϳ55 mV) and have a characteristically different response to ACh. These two criteria were used to discriminate between endothelial and smooth muscle intracellular recordings.
Lymphatic smooth muscle impalements were characterized by a sharp drop in potential that settled after 10 -15 s to a value typically more negative than Ϫ45 mV. Impalements were maintained for Ͼ5 min in Ͼ90% of the cases and Յ3 h optimally. CPA was added to the PSS that superfused the preparation either for short (1 min) or longer (4 -10 min) durations. In experiments where the effects of CPA were assessed in the presence of inhibitors
, and glibenclamide}, CPA was applied first as a control and then at least 20 min later in the presence of the antagonist, which had been superfused for at least 10 min. This protocol was usually performed during the same impalement. However, in some instances, successive impalements were obtained from neighboring cells in the same segment. There was no significant difference in the responses for repeated treatments of CPA applied at the same concentration 20 min apart.
STD activity was assessed by measuring the frequency and amplitude of events Ͼ1 mV in size. STD frequency and amplitude were measured for 15-60 s (depending on the stability of the recording, but typically 30 s) before application of CPA (or other agonists: U-46619, norepinephrine, thimerosal) and were then compared with those occurring for a period of the same duration during the time period when response to the agonist was maximal.
Functional removal of endothelium. The lymphatic endothelium was destroyed in vitro after a procedure that has been previously described (11, 12) . Briefly, a fine glass micropipette was inserted into the lumen of a previously cut vessel. The micropipette, which was connected to an infusion pump via Teflon tubing, was used to luminally perfuse the vessel with PSS in the direction of the valves. This procedure induced rhythmic constrictions of the vessel. To functionally destroy the endothelium, small air bubbles were passed in repeated streams (5-6 times for 5-10 s; rate, 3-5 l/min) through the vessel lumen via this micropipette. The success of the endothelial destruction was confirmed by applying ACh (10 M) before sodium nitroprusside (100 M) in the superfusion solution while the vessel lumen was perfused. An absence of an ACh-induced decrease in contractions as is observed in endothelium-intact vessels and a decrease in contractions to sodium nitroprusside were used as confirmation of the success of the procedure. Endothelial destruction based on this testing procedure proved successful in ϳ50% of treated vessels. The use of sodium nitroprusside was necessary, as it has been shown that 40% of guinea pig mesenteric lymphatic vessels with intact endothelium exhibit a high basal production of NO and hence do not respond in any way to either ACh or sodium nitroprusside (54). Loss of function of the endothelium was further confirmed during the electrophysiological experiments by the absence of endotheliumderived hyperpolarization and an inability to significantly change STD activity in response to 10 M ACh. Membrane potential responses to ACh are very reliable, as they occur in Ͼ95% of the cells with functional endothelium.
Ratiometric measurement of [Ca 2ϩ ]i. Experiments involving measurement of [Ca 2ϩ ]i changes in the lymphatic smooth muscle or endothelium were performed using the calcium-sensing fluorescent dye fura-2. The smooth muscle of lymphatic vessels was loaded by luminally perfusing endothelium-denuded vessels at room temperature with the membrane permeant fura-2 acetoxymethyl ester (AM, 2 M) and pluronic acid (0.2% wt/vol) for 30 min. The same procedure was used in endothelium-intact vessels to specifically load the endothelium. After this, the vessel was perfused with control solution for 10 min to wash out extraneous dye. The vessel was then left for an equilibration time of at least 20 min to allow the intracellular esterases to cleave fura-2 AM (14) . The mesentery was hooked on small pins glued to the outside of a metal frame (1 ϫ 1 cm) such that the frame positioned the mesentery and associated lymphatic vessels flat against the glass coverslip that formed the bottom of the organ bath (volume, 0.5 ml). The tissue was superfused with heated (34 -36°C) PSS at a rate of 6 ml/min, and regions of individual vessel chambers (lymphangions) were viewed by an inverted microscope (Zeiss Axiovert 10) using a ϫ40 oil-immersion objective (numerical aperture, 1.3). Ratiometric experiments were made photometrically on vessel chambers. Each such measurement incorporated the response from multiple endothelial or smooth muscle cells in endothelium-intact or -denuded vessels, respectively.
Ratiometric fura-2 measurements were made with vessel chambers alternatively illuminated by a xenon lamp at 340-and 380-nm wavelengths for durations of 50 ms for each wavelength with a 50-ms interval between each exposure. This cycle was repeated at a frequency of ϳ5 Hz. Emission light was passed through a dichroic mirror (490 nm) and a band-pass filter (510 nm) and collected by a photomultiplier; the output response was digitized and captured by computer. Experiments were performed in the absence of luminal perfusion to minimize movement. These movements were then sufficiently small to allow the fura-2-loaded smooth muscle or endothelium to remain in the focal plane. Such movement could in some cases cause the fluorescence at the 380-nm wavelength (F380) to increase instead of decrease. This most likely occurred due to more dye-loaded tissue moving into focus and causing a net increase in F380 fluorescence. This is accounted for by a proportional change in the signal for fluorescence at the 340-nm wavelength (F340) so that the ratio cancels out such movement artifacts if the ratios are obtained at a time interval of sufficiently short duration during which movement is small. Independent measurement of constrictions suggests that this was upheld during most of the constriction except for the period of maximum onset when there was some error. Vessel chambers typically constricted to peak amplitude in Ͻ0.5 s and then decayed relatively slowly to baseline over the next 2-3 s. The protocol used to measure the F 340/F380 ratios incurred a maximum interval between ratios of 100 ms during which there could be up to ϳ25% movement during the maximum-onset phase of constriction but less than ϳ5% during the decay phase. Thus the ratios would only be substantially distorted during the maximum-onset phase of constriction (i.e., during the first 0.5 s of the Ca 2ϩ transient). Chemicals and drugs. ACh, CPA, glibenclamide, L-NNA, norepinephrine, sodium nitroprusside, and thimerosal were all purchased from Sigma; fura-2 AM was from Molecular Probes (Eugene, OR), ODQ was from Alexis (San Diego, CA), and U-46619 was from Cayman Chemicals (Ann Arbor, MI). CPA, fura-2 AM, glibenclamide, ODQ, and U-46619 were dissolved in dimethylsulfoxide; L-NNA was dissolved in 0.1 M HCl, and the remainder were dissolved in distilled water to yield 10 mM stock solutions. After dilution of the drugs to their final concentrations in physiological saline, the diluted vehicle had no effects on tissue activity.
Data analysis. Experimental data are expressed as means Ϯ SE. Statistical significance was assessed using a two-tailed, paired Student's t-test (unless specified otherwise in the text) with P Ͻ 0.05 being considered significant.
RESULTS
Effects of CPA on STDs and smooth muscle membrane potentials. CPA (1-10 M) caused a concentration-dependent hyperpolarization of the smooth muscle (Fig. 1, A and B) . The hyperpolarization reached a peak value of 7.9 Ϯ 1.3 mV at 10 M CPA from a resting value of Ϫ50.4 Ϯ 1.0 mV (n ϭ 21). During the hyperpolarization, the activity of STDs, which occurred in ϳ95% of the lymphatic smooth muscle recordings (see Refs. 48, 54) was also reduced in a concentration-dependent manner (Fig. 1, C and D) . At the peak of the hyperpolarization induced by CPA (10 M), STD frequency was significantly reduced to 48 Ϯ 7% of control and STD amplitude declined to 76 Ϯ 4% of control (n ϭ 21; P Ͻ 0.01). In five recordings, the CPA-induced hyperpolarization was preceded by a small depolarization of 1-4 mV and an associated increase in STD frequency and amplitude (143 Ϯ 24 and 134 Ϯ 11% of control, respectively). Alterations in STD activity and hyperpolarization persisted for 3-5 min after the CPA had been washed out before returning to control values.
Role of endothelium and EDNO in CPA-induced hyperpolarization. Studies on blood vessels have shown that CPA induces the release of EDNO from endothelial cells, which causes vasodilation (33, 43, 61) . Therefore, as EDNO is known to modulate lymphatic smooth muscle membrane potential (54, 57), we investigated the roles of lymphatic endothelium and EDNO in the hyperpolarization in response to CPA. In the first set of experiments, the response of the smooth muscle membrane potential to CPA was evaluated in endothelium-denuded lymphatic vessels. In this situation, the known endotheliumdependent hyperpolarization in response to ACh (54) was abolished ( Fig. 2A) . Application of CPA (10 M for Ͼ5 min) caused a small depolarization of 2.0 Ϯ 0.8 mV, whereas the hyperpolarization was reduced to 1.0 Ϯ 1.1 mV (n ϭ 6; P ϭ 0.34; Fig. 2A ).
In the second set of experiments, lymphatic vessels were superfused with L-NNA (100 M) to inhibit the synthesis of EDNO or ODQ (10 M) and block the production of cGMP. Again, success of the treatments was attested by the inhibition of ACh-induced hyperpolarization (data not shown). In the presence of L-NNA, the hyperpolarization induced by 10 M CPA was no longer significant (e.g., 2.2 Ϯ 1.1 mV; n ϭ 10; P ϭ 0.08). It was preceded by a depolarization of 8.3 Ϯ 2.4 mV (n ϭ 10; Fig. 2B ). In one of the 10 preparations, the CPA-induced responses were not significantly affected by the L-NNA treatment. In the presence of ODQ (10 M), the hyperpolarization induced by 10 M CPA was inhibited to nonsignificant levels (0.9 Ϯ 2.8 mV; n ϭ 7; P ϭ 0.2) thus unmasking a depolarization of 2.1 Ϯ 0.6 mV (Fig. 2C) . The same finding was also made when CPA was applied in the presence of glibenclamide (10 M) with the hyperpolarization again nonsignificant (1.5 Ϯ 1.0 mV) and the response then dominated by a depolarization of 2.5 Ϯ 0.9 mV (n ϭ 4; data not shown).
Endothelium-independent effects of CPA on STDs. To avoid the confounding involvement of EDNO, the effects of 10 M CPA on smooth muscle STD activity were investigated either on endothelium-denuded vessels or in the presence of 100 M L-NNA or 10 M ODQ. As illustrated in Fig. 2A , in endothelium-denuded vessels, lymphatic smooth muscle responded to 10 M CPA with an initial and transient increase in STD activity that was associated with a small depolarization (108 Ϯ 7 and 115 Ϯ 11% of control for frequency and amplitude, respectively; n ϭ 4) that sometimes culminated in action potentials. This phase, which lasted for 1-2 min, was then followed by a marked and prolonged CPA-induced decrease in STD activity. STD frequency and amplitude were reduced to 42 Ϯ 13 and to 77 Ϯ 4% of control, respectively (n ϭ 6; Fig.  2D ). Similar findings were identified in the presence of L-NNA or ODQ (10 M) with respective CPA-induced decreases in STD frequency and amplitude of 32 Ϯ 6 and 62 Ϯ 7% of control for L-NNA (n ϭ 9; Fig. 2D ) and 52 Ϯ 11 and 70 Ϯ 5% of control for ODQ (n ϭ 6). These values were in all cases not significantly different from the responses induced by 10 M CPA on smooth muscle in vessels with functional endothelium (P Ͼ 0.1 for all cases, unpaired Student's t-test). Upon washout of the CPA, the membrane potential repolarized to control values, sometimes with a transient hyperpolarization, whereas STD activity returned to control levels within 3-5 min.
Endothelium-independent effects of CPA on agonist-evoked STDs. The effects of CPA were also investigated during agonist-induced enhancement of STD activity. As described in the previous section, these experiments were performed under conditions where the EDNO contribution was minimized. Experiments were first performed using the thromboxane A 2 mimetic U-46619. At a concentration of 0.1 M, U-46619 increased STD frequency and amplitude (n ϭ 6; (Fig. 4A) . The U-46619-induced increase in STD activity was significantly reduced below control levels (P Ͻ 0.05) during application of 10 M CPA to vessel segments (n ϭ 6; Fig. 3, A and D) . Experiments were also performed in the presence of norepinephrine, which enhances STD activity through activation of ␣-adrenoceptors ( Fig. 3D; Ref. 48 ). Application of 10 M CPA to vessel segments exposed to 10 -50 nM norepinephrine reduced STD frequency and amplitude (n ϭ 4; P Ͻ 0.05; Fig.  3, B and D) . The third activator used was thimerosal, an agent reported to sensitize inositol 1,4,5-trisphosphate (IP 3 ) receptors and lead to enhancement of IP 3 -induced Ca 2ϩ release (4, 5, 18) . Application of 1 M thimerosal increased STD frequency and amplitude to 128 Ϯ 12 and 148 Ϯ 35% of control, respectively (n ϭ 5). Application of 10 M CPA to vessel segments exposed to 1 M thimerosal reduced STD frequency and amplitude to values below control (n ϭ 5; Fig. 3, C and D) . ] i to 116 Ϯ 1% (n ϭ 3); this finding is consistent with that previously reported (60) . Transient spikelike increases in [Ca 2ϩ ] i were occasionally observed. This activity underlies action potential-induced constrictions (i.e., vasomotion) and could be increased by super- fusing the preparation with PSS that contained U-46619 (57). This is exemplified in Fig. 4B , where U-46619 (0.1 M) increased [Ca 2ϩ ] i and induced oscillations that led to moresynchronized spikelike Ca 2ϩ transients. The frequency of these spikelike transients was in some cases increased with the application of 10 M CPA, which then blocked this activity while the [Ca 2ϩ ] i was increased to 115 Ϯ 1% of its value in the presence of U-46619 (n ϭ 3; Fig. 4B ).
These effects closely compare with the action of CPA on the smooth muscle membrane potential shown in Fig. 4A . In this preparation, U-46619 was added at a concentration that increased STD activity and caused a transient depolarization of the membrane potential and near-rhythmic generation of action potentials. Application of CPA (10 M) in the continued presence of U-46619 caused a gradual depolarization during which there was an initial increase in the frequency of action potentials and subsequent inhibition of these events (Fig. 4A) .
Direct action of CPA on endothelium. The effects of CPA on the endothelium were investigated by measuring changes in both [Ca 2ϩ ] i and membrane potential. CPA (10 M) caused [Ca 2ϩ ] i to increase to 123 Ϯ 2% of control (n ϭ 3), which is a value similar to that obtained in the same preparations with 10 M ACh (122 Ϯ 5%). However, the kinetics of the onset of the increase in [Ca 2ϩ ] i occurred some 10-fold slower for CPA than for ACh with the times for the response to increase to 50% of peak amplitude 103 Ϯ 7 and 10 Ϯ 1 s, respectively (Fig. 5A) .
Endothelial cells of guinea pig mesenteric lymphatic vessels have been shown to be very polarized with a resting membrane potential of about Ϫ72 mV (56) . In the present study, the mean resting membrane potential was Ϫ73.5 Ϯ 1.1 mV (n ϭ 6). This value was depolarized by 1.0 Ϯ 0.4 mV in the first minute of application of 10 M CPA (n ϭ 6); during this interval, the bath solution was fully exchanged (see METHODS) and in the same cells, ACh induced a marked depolarization (18.2 Ϯ 3.4 mV). However, during longer applications of CPA, a slow depolarization developed (time to peak, 6 -7 min) that reached a maximum value of 18.5 Ϯ 3.3 mV, which is close to the maximum response obtained with 10 M ACh (Fig. 5B) . Although the ACh response was sometimes preceded by a small hyperpolarization (1.2 Ϯ 0.7 mV; n ϭ 6; see also Ref. 56) , this was not observed in response to CPA.
DISCUSSION
The present study investigated the effects of CPA, a selective inhibitor of Ca 2ϩ -ATPase in smooth muscle SR (6, 8, 26, 45) , on pacemaker activity in guinea pig mesenteric lymphatic vessels. CPA caused a complex response that was characterized by changes in the smooth muscle resting membrane potential and the activity of STDs and a slowing in the frequency of [Ca 2ϩ ] i transients. The major action was mediated by direct action of CPA on smooth muscle, although the endothelium also played a role through CPA-induced release of EDNO.
CPA caused the lymphatic smooth muscle membrane potential to hyperpolarize and the STD frequency and amplitude to decrease. The hyperpolarization was shown to be primarily mediated by the CPA-induced production and release of NO from the lymphatic endothelium, as it was strongly reduced in the presence of L-NNA and ODQ as well as in vessels with nonfunctional endothelium. Inhibition of CPA-induced hyperpolarization by glibenclamide further suggests an involvement of EDNO, as NO has been shown to activate ATP-sensitive K ϩ channels in the same lymphatic vessels (53) . Although NO itself has been shown to reduce STD activity (57), we demonstrate here that the CPA-induced decrease in STD activity was largely independent of EDNO, as CPA still markedly reduced STD activity while endothelial function or NO production was impaired. Consistent with results obtained from other smooth muscles (15, 16, 50) , our findings suggest that CPA acts directly on lymphatic smooth muscle to inhibit STD generation. At the concentration range used in the present study (1-10 M), CPA has been reported to selectively alter SR Ca 2ϩ -ATPase function in smooth muscle (see Refs. 6, 45) . The decrease in lymphatic smooth muscle STD activity is thus likely to result from the action of CPA on Ca 2ϩ -ATPase, and it correlates with the expected effect of CPA on intracellular Ca 2ϩ handling. Moreover, the small depolarization and initial increase in STD activity that were observed early during CPA superfusion may be explained by the transient increase in [Ca 2ϩ ] i , which is thought to occur as a first event before store depletion, when the reuptake of Ca 2ϩ into the SR is altered (21, 41, 58) . Consistent with this, we found that CPA increased [Ca 2ϩ ] i (see also Ref. 60) . The actions of CPA on pacemaker events were also assessed in the presence of norepinephrine and the thromboxane A 2 mimetic U-46619. These agonists have been shown to increase lymphatic pacemaker activity (12, 20, 30, 39, 48, 57) most likely through increased production of IP 3 (9, 35) . Pacemaker events (i.e., large STDs or summations thereof) are interpreted to reflect synchronized release of Ca 2ϩ from localized groups of IP 3 receptor-operated stores: the Ca 2ϩ release generates inward current through activation of pathways such as Ca 2ϩ -activated Cl Ϫ channels (see Ref; 22) . Recent studies on pacemaking in another smooth muscle (guinea pig gastric pylorus) indicate that IP 3 -mobilizing agonists induce pacemaking by enhancing the number of active IP 3 receptor-operated stores, and these are then entrained by a coupled oscillator-based mechanism to generate large-amplitude pacemaker potentials (49) . This interpretation fits with the known actions of norepinephrine and U-46619 to enhance lymphatic vasomotion and underlying STD activity. It also fits with the finding of similar actions by the thiol-oxidizing reagent thimerosal, which at the concentration used (1 M) is known to selectively stimulate Ca 2ϩ release by sensitizing IP 3 and/or ryanodine receptors (dependent on the tissue; Refs. 1, 4, 5, 18, 38, 43) . Importantly, CPA actions to reduce Ca 2ϩ -release events measured by recording STDs are also consistent with this model, as stores would be depleted by CPA-induced block of the store Ca 2ϩ ATPase (21, 41) . However, the finding that there was residual STD activity in the absence or presence of the agonists indicates that CPA-induced inhibition of store function is incomplete for the range of CPA concentrations tested or that additional sources of Ca 2ϩ are available for STDs to occur.
Investigations of CPA action on the lymphatic endothelium revealed an increase in endothelial [Ca 2ϩ ] i upon CPA stimulation. Although observed here for the first time in lymphatic endothelium, CPA-induced increases in endothelial [Ca 2ϩ ] i are well documented in many vascular preparations (17, 24, 25) . The increase in endothelial [Ca 2ϩ ] i caused by CPA, like that caused by many other agonists, has been shown to be necessary to the release of endothelium-derived substances such as EDNO (19, 33, 61) . The lymphatic endothelium plays an important role in modulating lymphatic pumping (10, 37, 59) . In particular, the lymphatic endothelium was shown to slow lymphatic pumping by releasing EDNO both in vitro (32, 40, 54, 59 ) and in vivo (42) . An increase in endothelial [Ca 2ϩ ] i , which is associated with the production and release of EDNO, has also been demonstrated in lymphatic vessels of the guinea pig mesentery in response to ACh (54). This ACh-induced action is accompanied by marked depolarization of the lymphatic endothelium (56) . These findings are consistent with the present observations that CPA increases lymphatic endothelial [Ca 2ϩ ] i and depolarizes membrane potential. However, the rates for both of these changes were much slower than those observed in response to ACh, which is consistent with CPA acting through recruitment of different mechanisms. A gradual increase in [Ca 2ϩ ] i with a similar time course has been reported for the CPA-induced response of rabbit valvular endothelial cells (25) . Although membrane potential was not measured in the latter study, a CPA-induced increase in [Ca 2ϩ ] i in rabbit aortic valvular endothelial cells has been associated with hyperpolarization of endothelium (36) . Hyperpolarizations to vasoactive agonists have been described for many endothelial cells and are proposed to provide the electrochemical driving force for Ca 2ϩ entry into endothelial cells (see Ref. 23 ) thus promoting the Ca 2ϩ -dependent production of EDNO (27) . The finding that the lymphatic endothelium underwent depolarization in response to CPA and ACh does not fit this logic, but such responses have also been reported for some vascular endothelial cells in response to vasoactive substances or Ca 2ϩ -ATPase inhibitors (29, 31, 47) .
In conclusion, responses of lymphatic smooth muscle to CPA are suggested to be mediated by two mechanisms: a direct action of CPA through depletion of smooth muscle Ca 2ϩ stores, which inhibits the activity of pacemaker-associated Ca 2ϩ release events measured as STDs, and an action of CPA on endothelium to release EDNO, which causes smooth muscle to hyperpolarize and decrease STD activity. Both actions are proposed to contribute to a decrease in lymphatic pacemaking and the resultant propulsion of lymph. 
